Pentixapharm Holding AG (FRA:PTP)

Pentixapharm Holding AG Cash Flow Statement

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024
Period Ending	Mar 31, 2025	Dec 31, 2024
Net Income	-16.86	-13.98
Depreciation & Amortization	0.97	0.07
Asset Writedown & Restructuring Costs	19.01	19.01
Other Operating Activities	-3.86	-3.7
Change in Accounts Receivable	-1.95	-7.64
Change in Accounts Payable	-6.89	-0.21
Change in Other Net Operating Assets	-	-0.28
Operating Cash Flow	-9.57	-6.73
Capital Expenditures	-0.61	-0.62
Cash Acquisitions	8.71	8.71
Investing Cash Flow	8.1	8.08
Issuance of Common Stock	19.89	19.89
Repurchase of Common Stock	-0.47	-0.47
Other Financing Activities	-0.62	3.52
Financing Cash Flow	18.8	22.94
Net Cash Flow	17.34	24.29
Free Cash Flow	-10.17	-7.35
Free Cash Flow Margin	-7424.09%	-524.24%
Free Cash Flow Per Share	-0.41	-0.30
Cash Income Tax Paid	0.06	0.06

Source: S&P Global Market Intelligence. Standard template. Financial Sources.